Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Veltmann

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
European Journal of Heart Failure|November 6, 2014
Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillatorDavid Duncker, Arash Haghikia, Thorben König, et al.
Heart Rhythm|April 27, 2005
Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndromeChristian Wolpert, Constanze Echternach, Christian Veltmann, et al.
ESC Heart Failure|June 14, 2021
Author reply: S-ICD eligibilities in adults with congenital heart diseaseChristos Zormpas, Ann Sophie Silber-Peest, Jörg Eiringhaus, et al.
ESC Heart Failure|February 4, 2021
Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart diseaseChristos Zormpas, Ann Sophie Silber-Peest, Jörg Eiringhaus, et al.
Pacing and Clinical Electrophysiology : PACE|July 24, 2023
Utilization of 3D mapping systems in interventional electrophysiology and its impact on procedure time and fluoroscopy-Insights from the "Go for Zero Fluoroscopy" projectChristos Zormpas, Henrike Aenne Katrin Hillmann, Stephan Hohmann, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 25, 2010
Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathyStephan Fluechter, Jürgen Kuschyk, Christian Wolpert, et al.
International Journal of Cardiology|September 2, 2020
Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathiesJürgen Kuschyk, Johanna Müller-Leisse, David Duncker, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 11, 2009
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challengesChristian Veltmann, Christian Wolpert, Frederic Sacher, et al.
Canadian Journal of Physiology and Pharmacology|December 18, 2010
Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2Jonathan M Cordeiro, Guillermo J Perez, Nicole Schmitt, et al.
Heart Rhythm|September 11, 2010
Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndromeTheano Papavassiliu, Christian Veltmann, Christina Doesch, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
European Journal of Heart Failure|November 6, 2014
Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillatorDavid Duncker, Arash Haghikia, Thorben König, et al.
Heart Rhythm|April 27, 2005
Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndromeChristian Wolpert, Constanze Echternach, Christian Veltmann, et al.
ESC Heart Failure|June 14, 2021
Author reply: S-ICD eligibilities in adults with congenital heart diseaseChristos Zormpas, Ann Sophie Silber-Peest, Jörg Eiringhaus, et al.
ESC Heart Failure|February 4, 2021
Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart diseaseChristos Zormpas, Ann Sophie Silber-Peest, Jörg Eiringhaus, et al.
Pacing and Clinical Electrophysiology : PACE|July 24, 2023
Utilization of 3D mapping systems in interventional electrophysiology and its impact on procedure time and fluoroscopy-Insights from the "Go for Zero Fluoroscopy" projectChristos Zormpas, Henrike Aenne Katrin Hillmann, Stephan Hohmann, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 25, 2010
Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathyStephan Fluechter, Jürgen Kuschyk, Christian Wolpert, et al.
International Journal of Cardiology|September 2, 2020
Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathiesJürgen Kuschyk, Johanna Müller-Leisse, David Duncker, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 11, 2009
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challengesChristian Veltmann, Christian Wolpert, Frederic Sacher, et al.
Canadian Journal of Physiology and Pharmacology|December 18, 2010
Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2Jonathan M Cordeiro, Guillermo J Perez, Nicole Schmitt, et al.
Heart Rhythm|September 11, 2010
Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndromeTheano Papavassiliu, Christian Veltmann, Christina Doesch, et al.
Pageof 15